Cognex Cp (CGNX) 43.88 $CGNX Can Cognex (CGNX) Keep the

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cognex Cp (CGNX) 43.88 $CGNX

Can Cognex (CGNX) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Cognex (CGNX) currently has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
CGNX: 43.88 (-0.81)

Itron (ITRI) Scales New 52-Week High on Healthy Prospects
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:09AM CDT
On Jun 6, 2016, shares of Itron, Inc. (ITRI) scaled a new 52-week high of $45.20.
ITRI: 44.05 (-1.27), A: 45.36 (-0.73), CGNX: 43.88 (-0.81), ADTN: 18.83 (-0.16)

Gaining Ground: RoviSys Adds Darin Fox as Business Development Manager
PRWeb - Tue Jun 07, 2:58AM CDT
RoviSys, a leading independent provider of comprehensive process automation and control solutions and services based in Aurora, Ohio, announces the addition of Darin Fox as Business Development Manager, further filling out its team of business development specialists in the Southeast United States.
CGNX: 43.88 (-0.81)

Cognex to Present at the Nasdaq 34th Investor Program
BusinessWire - Thu Jun 02, 3:06PM CDT
Cognex Corporation (NASDAQ: CGNX) announced today that Richard A. Morin, Executive Vice President and CFO of Cognex, will discuss the company's performance and future prospects at the Nasdaq 34th Investor Program at The May Fair Hotel in London, UK. Mr. Morin's presentation will be on Thursday, June 16, beginning at 11:45 a.m. local time.
CGNX: 43.88 (-0.81)

Itron Hits 52-Week High on Upbeat Preliminary Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed May 25, 9:57AM CDT
On May 24, 2016, shares of Itron, Inc. (ITRI) scaled a new 52-week high of $43.61, before closing a notch lower at $43.50.
ITRI: 44.05 (-1.27), A: 45.36 (-0.73), CGNX: 43.88 (-0.81), ADTN: 18.83 (-0.16)

Cognex to Present at the Baird Global Consumer, Technology & Services Conference
BusinessWire - Wed May 18, 3:28PM CDT
Cognex Corporation (NASDAQ: CGNX) announced today that Robert J. Willett, President and CEO of Cognex, will discuss the company's performance and future prospects at the Baird Global Consumer, Technology & Services Conference at the JW Marriott Essex House, New York, NY. Mr. Willett's presentation will be on Wednesday, June 8, beginning at 2:35 p.m. Eastern Time.
CGNX: 43.88 (-0.81)

Itron (ITRI) Stock Gains on Upbeat Preliminary Q1 Results
Zacks Equity Research - Zacks Investment Research - Thu May 05, 6:43AM CDT
Itron, Inc. (ITRI) announced selected operating results for the first quarter.
ITRI: 44.05 (-1.27), BMI: 74.76 (-1.79), TSM: 25.86 (-0.37), CGNX: 43.88 (-0.81)

Cognex Corporation Soars After Strong Earnings
Lee Samaha, The Motley Fool - Motley Fool - Tue May 03, 2:06PM CDT
COGNEX HAS HIGH HOPES FOR ITS MOBILE TERMINAL. IMAGE SOURCE: COGNEX CORPORATION.  Machine vision company Cognex Corporation 's first-quarter results easily beat management's guidance, and the forecast for the second quarter indicates a strong...
CGNX: 43.88 (-0.81)

Cognex beats Street 1Q forecasts
Automated Insights - Mon May 02, 3:29PM CDT
NATICK, Mass. (AP) _ Cognex Corp. (CGNX) on Monday reported first-quarter net income of $14.9 million.
CGNX: 43.88 (-0.81)

Cognex Reports First Quarter 2016 Results
BusinessWire - Mon May 02, 3:06PM CDT
Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the first quarter of 2016. In Table 1 below, selected financial data for the quarter ended April 3, 2016 is compared to the first and fourth quarters of 2015. A reconciliation of certain financial measures from GAAP to non-GAAP is shown in Exhibit 2 of this news release.
CGNX: 43.88 (-0.81)

Cognex Increases Quarterly Cash Dividend
BusinessWire - Mon May 02, 3:06PM CDT
Cognex Corporation (NASDAQ: CGNX) announced today that the company's Board of Directors increased its quarterly cash dividend to $0.075 per share. This dividend is payable on June 17, 2016 to all shareholders of record at the close of business on June 3, 2016.
CGNX: 43.88 (-0.81)

3 Things to Look Out for When Cognex Corporation Reports Earnings
Lee Samaha, The Motley Fool - Motley Fool - Tue Apr 26, 1:04PM CDT
What to expect from 's upcoming first-quarter results on May 2? In a simple world, we would be able to pencil in a series of assumptions based on global manufacturing trends and quickly conclude that Cognex is heading for the kind of OK-ish...
CGNX: 43.88 (-0.81), AAPL: 98.83 (-0.82)

Cognex Enters Mobile Terminal Market
BusinessWire - Mon Apr 04, 7:00AM CDT
Cognex Corporation (NASDAQ: CGNX), the world's leading supplier of machine vision systems and industrial barcode readers used in factory automation and logistics, today announced that it has developed, and is now offering for sale, a totally new product line--ruggedized mobile terminals.
CGNX: 43.88 (-0.81)

Global Robotic Vision Market Worth USD 5.18 Billion by 2020 - Analysis, Technologies & Forecasts Report 2015-2020 - Key Vendors: Adept Technology, Cognex Corp, Faro Technologies - Research and Markets
BusinessWire - Fri Mar 25, 5:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/64rx8v/robotic_vision) has announced the addition of the "Robotic Vision Market by Component, Technology, Application, Industry, and Geography - Global Forecast to 2020" report to their offering.
ADEP: 12.98 (unch), CGNX: 43.88 (-0.81)

Cognex Announces First Quarter Earnings Release Date and Conference Call
BusinessWire - Wed Mar 23, 7:06AM CDT
Cognex Corporation (NASDAQ: CGNX) will release earnings for the first quarter of 2016 on Monday, May 2, 2016, after the market closes, and will host a conference call that same day at 5:00 p.m. Eastern Time (ET). The earnings release and conference call are scheduled to coincide with the company's expected filing of its Form 10-Q for the quarter ending April 3, 2016.
CGNX: 43.88 (-0.81)

Cognex Has Returned 13.1% Since SmarTrend Recommendation (CGNX)
Comtex SmarTrend(R) - Wed Mar 02, 11:57AM CST
SmarTrend identified an Uptrend for Cognex (NASDAQ:CGNX) on February 16th, 2016 at $34.16. In approximately 2 weeks, Cognex has returned 13.07% as of today's recent price of $38.62.
CGNX: 43.88 (-0.81)

Cognex tops Street 4Q forecasts
Automated Insights - Wed Feb 10, 3:36PM CST
NATICK, Mass. (AP) _ Cognex Corp. (CGNX) on Wednesday reported fourth-quarter profit of $18.7 million.
CGNX: 43.88 (-0.81)

Cognex Reports Fourth Quarter and Full Year 2015 Results
BusinessWire - Wed Feb 10, 3:06PM CST
Cognex Corporation (NASDAQ: CGNX) today announced its financial results for the fourth quarter and year ended December 31, 2015. In Table 1 below, selected financial data for the quarter and year are compared to the third quarter of 2015, the fourth quarter of 2014 and the year ended December 31, 2014. A reconciliation of certain financial measures from GAAP to non-GAAP is shown in Exhibit 2 of this news release.
CGNX: 43.88 (-0.81)

33.5% Return Seen to Date on SmarTrend Cognex Call (CGNX)
Comtex SmarTrend(R) - Fri Feb 05, 9:50AM CST
SmarTrend identified a Downtrend for Cognex (NASDAQ:CGNX) on June 30th, 2015 at $47.63. In approximately 7 months, Cognex has returned 33.49% as of today's recent price of $31.68.
CGNX: 43.88 (-0.81)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vanessa Hering's Empathetic Model Wins 2026 Herizon Award

Updated Category News Views 63

Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...

Continue Reading
Sesame Software's Game-Changer: Smooth CRM Switch

Updated Category News Views 80

Why Leaving Salesforce Isn't as Crazy as It Sounds Stepping away from Salesforce isn't your run-of-the-mill decision for businesses. It’s more like abandoning ship, anticipating lurking dangers: losing cherished data, facing burdensome API restrictions, and fretting over years of trapped history. It’s not as simple as flipping a switch, and that’s what keeps most...

Continue Reading
IGT and MGM Springfield Unveil Jackpot Games in MA

Updated Category News Views 64

Milestone Event in Massachusetts Gaming Scene When IGT and MGM Springfield team up to unveil the first wide-area progressive slots games in Massachusetts, it’s more than just a new game on the floor—it's a seismic shift in the region's gambling landscape. We've got twenty new shiny wheels turning over at the MGM Springfield, with jackpots starting at a hefty $1.125...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 37

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 59

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 49

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Mesirow Taps Shawn Beber as New CEO: Strategic Leap

Updated Category News Views 61

Beber's Big Move: Mesirow Bets on Experience When a company's betting big on its next move, it goes for someone who's seen a storm or two. Enter Shawn Beber. Mesirow's new main guy. The firm isn't playing small potatoes with this hire. Fresh off a long gig at CIBC, Beber brings a hefty bag of tricks and a track record of navigating the high seas, none more impressive than...

Continue Reading
Windward Expands Maritime Scope with Azimut.ai Deal

Updated Category News Views 129

An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...

Continue Reading
Hidden Fences: A Smarter Choice for Pet Owners?

Updated Category News Views 45

The Case for Invisible Fences Man's best friend meets modern containment! Why are hidden fences gaining traction in households across Culpeper, VA, and beyond? Pet Containment Expert Lawrence Sowers spills some valuable insights into why so many are ditching traditional fences. Practical reasons abound, folks! Keeping the Yard Beautiful Who wants their landscaping ruined...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 53

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading

Top 5 Most Recently Viewed Articles

Abeona Therapeutics Gears Up for Healthcare Conference Insights

Updated Category News Views 97

Abeona Therapeutics Gears Up for Healthcare Conference Insights CLEVELAND – Abeona Therapeutics Inc. (Nasdaq: ABEO) is set to make a significant impact at the upcoming Leerink Partners Global Healthcare Conference. The Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., will represent the company at this esteemed event, showcasing its innovative approaches in the...

Continue Reading
Clarivate Taps Global Appetite for AI Research Tools

Updated Category News Views 42

A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...

Continue Reading
Eve Holding, Inc. Announces Q2 2025 Financial Outcomes

Updated Category News Views 198

Eve Holding, Inc. Announces Q2 2025 Financial Outcomes Eve Holding, Inc. (NYSE: EVEX) recently revealed its financial results for the second quarter of 2025, showcasing remarkable insights into its developments in Urban Air Mobility (UAM). Financial Performance Overview The aerospace innovator, focused on electric Vertical Takeoff and Landing (eVTOL) aircraft, reported a...

Continue Reading
Strategic Insider Moves: Unpacking Sherwin-Williams Stock Options

Updated Category News Views 166

Insights into Recent Insider Activity at Sherwin-Williams A recent insider move has attracted attention as Jorgenrud, President at Sherwin-Williams (NYSE: SHW), has disclosed the acquisition of stock options for 10,860 shares. This strategic decision, which emphasizes confidence in the company's future, provides insight into the inner workings of the firm. Details of the...

Continue Reading
The Southern Banc Company, Inc. Reports Fourth Quarter 2025 Earnings

Updated Category News Views 166

The Southern Banc Company Financial Overview Gates Little, President and Chief Executive Officer of The Southern Banc Company, Inc. (OTCBB: SRNN), shared exciting preliminary results for the recent fiscal year-end quarter, highlighting financial performance for the period ending June 30, 2025. Fourth Quarter Earnings Details For the quarter, the Company reported a net...

Continue Reading